Audrey A. Wallace

1.6k total citations
29 papers, 1.0k citations indexed

About

Audrey A. Wallace is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Hematology. According to data from OpenAlex, Audrey A. Wallace has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 10 papers in Molecular Biology and 4 papers in Hematology. Recurrent topics in Audrey A. Wallace's work include Cardiac electrophysiology and arrhythmias (17 papers), Cardiac Arrhythmias and Treatments (13 papers) and Ion channel regulation and function (6 papers). Audrey A. Wallace is often cited by papers focused on Cardiac electrophysiology and arrhythmias (17 papers), Cardiac Arrhythmias and Treatments (13 papers) and Ion channel regulation and function (6 papers). Audrey A. Wallace collaborates with scholars based in United States and Japan. Audrey A. Wallace's co-authors include Joseph J. Lynch, Elizabeth Baskin, Raymond J. Winquist, Raymond F. Stupienski, Patricia B. Bunting, Robert B. Stein, Nancy K. Jurkiewicz, Joseph J. Salata, Gary L. Stump and Harold G. Selnick and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

Audrey A. Wallace

29 papers receiving 957 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Audrey A. Wallace United States	16	689	574	217	152	104	29	1.0k
Elizabeth Baskin United States	20	602 0.9×	625 1.1×	250 1.2×	158 1.0×	113 1.1×	28	1.2k
Bruno Le Grand France	22	795 1.2×	617 1.1×	57 0.3×	220 1.4×	182 1.8×	73	1.2k
Elizabeth P. Faison United States	11	805 1.2×	483 0.8×	240 1.1×	166 1.1×	38 0.4×	15	1.2k
Agnès Bénardeau Switzerland	23	657 1.0×	750 1.3×	236 1.1×	187 1.2×	57 0.5×	43	1.4k
Ross Bentley United States	19	369 0.5×	375 0.7×	212 1.0×	48 0.3×	29 0.3×	33	951
J.-P. Vilaine France	18	645 0.9×	241 0.4×	291 1.3×	72 0.5×	64 0.6×	23	1.0k
Subbarao Vemulapalli United States	17	283 0.4×	219 0.4×	211 1.0×	97 0.6×	34 0.3×	37	725
Carol A. Sargent United States	18	201 0.3×	429 0.7×	248 1.1×	95 0.6×	260 2.5×	36	932
K Tack-Goldman United States	10	463 0.7×	214 0.4×	216 1.0×	49 0.3×	57 0.5×	13	1.0k
Donald H. Namm United States	13	173 0.3×	251 0.4×	114 0.5×	66 0.4×	53 0.5×	16	579

Countries citing papers authored by Audrey A. Wallace

Since Specialization

Citations

This map shows the geographic impact of Audrey A. Wallace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Audrey A. Wallace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Audrey A. Wallace more than expected).

Fields of papers citing papers by Audrey A. Wallace

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Audrey A. Wallace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Audrey A. Wallace. The network helps show where Audrey A. Wallace may publish in the future.

Co-authorship network of co-authors of Audrey A. Wallace

This figure shows the co-authorship network connecting the top 25 collaborators of Audrey A. Wallace. A scholar is included among the top collaborators of Audrey A. Wallace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Audrey A. Wallace. Audrey A. Wallace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Isaacs, Richard C.A., Swati P. Mercer, Bruce D. Dorsey, et al.. (2010). P3 optimization of functional potency, in vivo efficacy and oral bioavailability in 3-aminopyrazinone thrombin inhibitors bearing non-charged groups at the P1 position. Bioorganic & Medicinal Chemistry Letters. 21(5). 1532–1535. 3 indexed citations

Isaacs, Richard C.A., Swati P. Mercer, Linda S. Payne, et al.. (2010). Design, synthesis and SAR of a series of 1,3,5-trisubstituted benzenes as thrombin inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(5). 1536–1540. 6 indexed citations

Regan, Christopher P., Gary L. Stump, Audrey A. Wallace, et al.. (2007). In Vivo Cardiac Electrophysiologic and Antiarrhythmic Effects of an Isoquinoline IKur Blocker, ISQ-1, in Rat, Dog, and Nonhuman Primate. Journal of Cardiovascular Pharmacology. 49(4). 236–245. 19 indexed citations

Regan, Christopher P., et al.. (2006). In Vivo Cardiac Electrophysiologic Effects of a Novel Diphenylphosphine Oxide IKur Blocker, (2-Isopropyl-5-methylcyclohexyl) Diphenylphosphine Oxide, in Rat and Nonhuman Primate. Journal of Pharmacology and Experimental Therapeutics. 316(2). 727–732. 29 indexed citations

Stump, Gary L., Audrey A. Wallace, Christopher P. Regan, & Joseph J. Lynch. (2005). In Vivo Antiarrhythmic and Cardiac Electrophysiologic Effects of a Novel Diphenylphosphine Oxide IKur Blocker (2-Isopropyl-5-methylcyclohexyl) Diphenylphosphine Oxide. Journal of Pharmacology and Experimental Therapeutics. 315(3). 1362–1367. 46 indexed citations

Stauffer, Kenneth J., Peter Williams, Terry A. Lyle, et al.. (2004). Low molecular weight thrombin inhibitors with excellent potency, metabolic stability, and oral bioavailability. Bioorganic & Medicinal Chemistry Letters. 14(16). 4161–4164. 16 indexed citations

Duggan, Mark E., Wasyl Halczenko, Carmen Fernández‐Metzler, et al.. (2003). Non-Peptide αvβ3 antagonists. Part 6: Design and synthesis of αvβ3 antagonists containing a pyridone or pyrazinone central scaffold. Bioorganic & Medicinal Chemistry Letters. 13(10). 1809–1812. 13 indexed citations

Sanderson, Philip E.J., Adel M. Naylor-Olsen, Franklin C. Clayton, et al.. (2003). 3-Amino-4-sulfonylpyridinone acetamide and related pyridothiadiazine thrombin inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(8). 1441–1444. 8 indexed citations

Lynch, Joseph J., Joseph J. Salata, Audrey A. Wallace, et al.. (2002). Antiarrhythmic Efficacy of Combined IKs and β-Adrenergic Receptor Blockade. Journal of Pharmacology and Experimental Therapeutics. 302(1). 283–289. 7 indexed citations

10.

Stump, Gary L., et al.. (2000). Arrhythmogenic potential of positive inotropic agents. Basic Research in Cardiology. 95(3). 186–198. 28 indexed citations

11.

Lynch, Joseph J., et al.. (1999). EXP3174, the AII antagonist human metabolite of losartan, but not losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarction. Journal of the American College of Cardiology. 34(3). 876–884. 12 indexed citations

12.

Lynch, Joseph J., et al.. (1996). Differential efficacy of the class III agent MK-499 against programmed stimulation-induced and ischemic-induced ventricular arrhythmias in a canine model of previous myocardial infarction.. Journal of Pharmacology and Experimental Therapeutics. 277(2). 671–678. 5 indexed citations

13.

Cook, Jacquelynn J., Marie A. Holahan, Denise Ramjit, et al.. (1996). Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217.. Journal of Pharmacology and Experimental Therapeutics. 278(1). 62–73. 18 indexed citations

14.

Wallace, Audrey A., Raymond F. Stupienski, Elizabeth Baskin, et al.. (1995). Cardiac electrophysiologic and antiarrhythmic actions of tedisamil.. Journal of Pharmacology and Experimental Therapeutics. 273(1). 168–175. 27 indexed citations

15.

Lynch, Joseph J., Audrey A. Wallace, Raymond F. Stupienski, et al.. (1994). Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499].. Journal of Pharmacology and Experimental Therapeutics. 269(2). 541–554. 43 indexed citations

16.

Wallace, Audrey A., et al.. (1993). Demonstration of Proarrhythmic Activity with the Class IC Antiarrhythmic Agent Encainide in a Canine Model of Previous Myocardial Infarction. Journal of Cardiovascular Pharmacology. 21(3). 397–404. 8 indexed citations

17.

Wallace, Audrey A., et al.. (1991). Cardiac Electrophysiologic and Inotropic Actions of New and Potent Methanesulfonanilide Class III Antiarrhythmic Agents in Anesthetized Dogs. Journal of Cardiovascular Pharmacology. 18(5). 687–695. 48 indexed citations

18.

Lynch, Joseph J., et al.. (1990). Suppression of Lethal Ischemic Ventricular Arrhythmias by the Class III Agent E4031 in a Canine Model of Previous Myocardial Infarction. Journal of Cardiovascular Pharmacology. 15(5). 764–775. 37 indexed citations

19.

Winquist, Raymond J., Audrey A. Wallace, Elizabeth Baskin, et al.. (1989). Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle.. Journal of Pharmacology and Experimental Therapeutics. 248(1). 149–156. 168 indexed citations

20.

Winquist, Raymond J., Patricia B. Bunting, Elizabeth Baskin, & Audrey A. Wallace. (1984). Decreased Endothelium-dependent Relaxation in New Zealand Genetic Hypertensive Rats. Journal of Hypertension. 2(5). 541–545. 157 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact